Home › Funds › 683 Capital Management, LLC › ZVRA
683 Capital Management, LLC position in ZVRA
ZEVRA THERAPEUTICS INC · Health Care
683 Capital Management, LLC reported holding 855,000 shares of ZVRA (ZEVRA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$12.3M, representing 0.65% of its reported portfolio and ranking #34 among its reported holdings. 683 Capital Management, LLC has disclosed ZVRA holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How 683 Capital Management, LLC's ZVRA position evolved
683 Capital Management, LLC first disclosed a stake in ZVRA in Q4 2023 at 540,800 shares (US$3.5M). The position peaked in Q2 2026 at 855,000 shares, worth US$12.3M. Across 11 filings, 683 Capital Management, LLC increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 855,000 shares valued at US$12.3M — a reduction of -120,000 shares quarter over quarter.. Notable position changes include a 48% increase in Q1 2024 (shares fell 16% over the following quarter), a 53% increase in Q3 2024 (shares rose 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 540.80K | $3.54M | New |
| Q1 2024 | 800.00K | $4.64M | Add |
| Q2 2024 | 800.00K | $3.92M | Hold |
| Q3 2024 | 1.23M | $8.50M | Add |
| Q4 2024 | 1.23M | $10.22M | Hold |
| Q1 2025 | 1.23M | $9.18M | Hold |
| Q2 2025 | 1.12M | $9.91M | Reduce |
| Q3 2025 | 975.00K | $9.27M | Reduce |
| Q4 2025 | 905.00K | $8.11M | Reduce |
| Q1 2026 | 975.00K | $9.09M | Add |
| Q2 2026 | 855.00K | $12.26M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZVRA and 13F data
ZVRA (ZEVRA THERAPEUTICS INC) is a Health Care company. 56 other funds we track also report a position in ZVRA — the largest reported positions include Nantahala Capital Management, LLC (US$25.8M), KINGDON CAPITAL MANAGEMENT, L.L.C. (US$11.1M), Retirement Planning Co of New England, Inc. (US$6.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZVRA
- Nantahala Capital Management, LLC 1.80M sh · $25.78M · Q2 2026
- KINGDON CAPITAL MANAGEMENT, L.L.C. 775.00K sh · $11.11M · Q2 2026
- Retirement Planning Co of New England, Inc. 612.33K sh · $6.72M · Q3 2026
- Mystic Asset Management, Inc. 355.38K sh · $3.90M · Q3 2026
- Stonepine Capital Management, LLC 258.70K sh · $3.71M · Q2 2026
- Propel Bio Management, LLC 253.54K sh · $3.64M · Q2 2026
- Diametric Capital, LP 231.47K sh · $3.32M · Q2 2026
More on 683 Capital Management, LLC
FAQ
How long has 683 Capital Management, LLC held ZVRA?
683 Capital Management, LLC has disclosed ZVRA holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is 683 Capital Management, LLC's current position in ZVRA?
As of Q2 2026, 683 Capital Management, LLC holds 855.00K shares of ZVRA (ZEVRA THERAPEUTICS INC), valued at $12.26M, representing 0.65% of its reported portfolio and ranking #34.
Has 683 Capital Management, LLC been buying or selling ZVRA?
In the latest 13F filing (Q2 2026), 683 Capital Management, LLC reduced its position in ZVRA. The position peaked in Q2 2026 at 855.00K shares.
Which other funds hold ZVRA?
Other major institutional holders of ZVRA include Nantahala Capital Management, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., Retirement Planning Co of New England, Inc., among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.